Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma

6Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

We performed loss of heterozygosity (LOH) analysis on five chromosomal arms (1p, 3p, 9p, 10q, 17p) in hepatocellular carcinoma (HCC). Univariate analyses of 80 patients who underwent liver transplantation demonstrated significant correlations between cancer recurrence and the following variables: LOH on 3p26, LOH on 10q23, LOH on 17p13, tumor diameter ≥ 5 cm, number of tumors ≥ 4, histologic Grade 3, alpha-fetoprotein (AFP) ≥ 400 ng/mL, American Joint Committee on Cancer (AJCC) pT classification, and portal invasion. Patients with LOH on 10q23 exhibited a significantly higher 3-year recurrence rate (38.9% vs 11.9%, P = 0.0009). Multivariate analysis identified LOH on 10q23, histologic Grade 3, tumor nodules ≥ 4, and AFP ≥ 400 ng/mL as the risk factors of advanced HCC recurrence. These results suggest that LOH on 10q23 is associated with metastatic recurrence of HCC. © 2009 Japanese Cancer Association.

Cite

CITATION STYLE

APA

Okuno, T., Ueda, M., Tsuruyama, T., Haga, H., Takada, Y., Maetani, Y., … Uemoto, S. (2009). Loss of heterozygosity on 10q23 is involved in metastatic recurrence of hepatocellular carcinoma. Cancer Science, 100(3), 520–528. https://doi.org/10.1111/j.1349-7006.2008.01056.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free